You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ahmedabad, India
  • +7 more
Jan 21, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 16, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, Best supportive/best standard of care

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 2, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Prostate Cancer Trial in Sapporo city, Kanazawa-city (177Lu-PSMA-617, 68Ga-PSMA-11, Best supportive/best standard of care)

Recruiting
  • Prostate Cancer
  • 177Lu-PSMA-617
  • +2 more
  • Kashiwa, Chiba, Japan
  • +6 more
Jan 23, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

Active, not recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • Duarte, California
  • +26 more
Aug 3, 2022

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Advanced Prostate Cancer Trial (HRS-5041)

    Not yet recruiting
    • Advanced Prostate Cancer
    • (no location specified)
    Jul 5, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

    Not yet recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • (no location specified)
    Nov 13, 2023

    Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)

    Not yet recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Feb 23, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Disitamab Vedotin（RC48-ADC）
    • (no location specified)
    Jul 13, 2023

    Hormone-refractory Prostate Cancer Trial (AMX-500)

    Not yet recruiting
    • Hormone-refractory Prostate Cancer
    • (no location specified)
    Aug 11, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Enzalutamide 40mg
    • +4 more
    • Bellinzona, Switzerland
    • +1 more
    Nov 6, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T
    • Oklahoma City, Oklahoma
      Stephenson's Cancer Center
    Mar 28, 2023

    Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • mCRPC
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Jul 20, 2022

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T Injection
    • (no location specified)
    Nov 10, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Aug 8, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (177Lu-PSMA-617, PSMA-11)

    No longer available
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 12, 2023

    Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

    Not yet recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
    Sep 22, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • New Haven, Connecticut
      Yale Cancer Center
    Oct 20, 2023